HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manu Vanaerschot Selected Research

Manu Vanaerschot Research Topics

Disease

9Visceral Leishmaniasis (Kala Azar)
01/2017 - 10/2010
6Malaria
01/2022 - 01/2018
2Parasitemia
12/2018 - 06/2014
2Infections
12/2018 - 01/2017
2Reinfection
10/2013 - 06/2013
1COVID-19
11/2023
1Aneuploidy (Aneuploid)
01/2020
1Asymptomatic Infections
01/2017
1Leishmaniasis
10/2013

Drug/Important Bio-Agent (IBA)

5Antimalarials (Antimalarial Agents)IBA
01/2021 - 12/2018
3miltefosine (Impavido)IBA
10/2013 - 06/2013
2DNA (Deoxyribonucleic Acid)IBA
11/2023 - 01/2020
2N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
10/2013 - 06/2013
1Acetate-CoA Ligase (Acetyl CoA Synthetase)IBA
01/2022
1InsecticidesIBA
01/2021
1alpha-aminopyridineIBA
01/2018
1MMV390048IBA
01/2018
11-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1Drug CombinationsIBA
04/2015
1QuinazolinesIBA
06/2014
1Genetic Markers (Genetic Marker)IBA
09/2012
1AntimonyIBA
01/2012
118S Ribosomal RNAIBA
10/2010

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2021 - 04/2015
2Therapeutics
01/2021 - 06/2013
1Aftercare (After-Treatment)
10/2013